The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography
- 1 March 1996
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 124 (1), 141-147
- https://doi.org/10.1007/bf02245614
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomographySynapse, 1992
- Striatal function in normal aging: Implications for Parkinson's diseaseAnnals of Neurology, 1990
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsPsychopharmacology, 1989
- Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patientsBiological Psychiatry, 1988
- In Vivo Assay for Neuroleptic Receptor Binding in the StriatumThe British Journal of Psychiatry, 1987
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- Persistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine TherapyThe British Journal of Psychiatry, 1972